A Propensity Score-Enhanced Sequential Analytic Method for Comparative Drug Safety Surveillance

Statistics in Biosciences

Volumn 3, Issue 1, 2011, Pages 45-62

  Li, Lingling ^a   Kulldorff, Martin ^a   Nelson, Jennifer C ^b   Cook, Andrea J ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Comparative effectiveness; CSSP; Drug safety surveillance; Electronic healthcare databases; Group sequential analysis; Propensity score

Indexed keywords

ADVERSE DRUG REACTION; ARTICLE; BINOMIAL DISTRIBUTION; CONDITIONAL SEQUENTIAL SAMPLING PROCEDURE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; INCIDENCE; MEASUREMENT ERROR; PRIORITY JOURNAL; PROBABILITY; PROPENSITY SCORE; SAMPLING; SIMULATION; STATISTICAL MODEL;

EID: 80053052507     PISSN: 18671764     EISSN: 18671772     Source Type: Journal    
DOI: 10.1007/s12561-011-9034-5     Document Type: Article

References (27)

1. Belongia EA, Irving SA, Shui IM, Kulldorff M, Lewis E, Yin RH, Lieu TA, Weintraub E, Yih WK, Li R, Baggs J Vaccine Safety Datalink Invest G (2010) Real-time surveillance to assess risk of intussusception and other adverse events after pentavalent, bovine-derived rotavirus vaccine. Pediatr Infect Dis J 29(1): 1-5. doi: 10. 1097/INF. 0b013e3181af8605.
2. Brown JS, Kulldorff M, Petronis KR, Reynolds R, Chan KA, Davis RL, Graham D, Andrade SE, Raebel MA, Herrinton L, Roblin D, Boudreau D, Smith D, Gurwitz JH, Gunter MJ, Platt R (2009) Early adverse drug event signal detection within population-based health networks using sequential methods: key methodologic considerations. Pharmacoepidemiol Drug Saf 18(3): 226-234.
3. Brown JS, Velentgas P, Kulldorff M, Moore KM, Duddy A, Platt R (2008) Implementation of rapid cycle analysis for detection of potential excess risk of adverse events following influenza vaccination: a policy maker's guide. Available at http://www. fda. gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Post-MarketActivities/ucm196253. htm.
4. Chen RT, Glasser JE, Rhodes PH, Davis RL, Barlow WE, Thompson RS, Mullooloy JP, Black SB, Shinefield H, Vadheim CM, Marcy SM, Ward JI, Wise RP, Wassilak SG, Hadler SC, The Vaccine Safety Datalink T (1997) Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the united states. Pediatrics 99: 765-773.
5. Davis RL, Kolczak M, Lewis E, Nordin J, Goodman M, Shay DK, Platt R, Black S, Shinefield H, Chen RT (2005) Active surveillance of vaccine safety: a system to detect early signs of adverse events. Epidemiology 16: 336-341.
6. Hernan MA, Brumback B, Robins JM (2000) Marginal structural models to estimate the causal effect of Zidovudine on the survival of HIV-positive men. Epidemiology 11(5): 561-570.
7. Jennison C, Turnbull BW (2000) Group sequential methods with applications to clinical trials. Chapman and Hall/CRC, London.
8. Klein NP, Fireman B, Yih WK, Lewis E, Kulldorff M, Ray P, Baxter R, Hambidge S, Nordin J, Naleway A, Belongia EA, Lieu T, Baggs J, Weintraub E, Vaccine Safety D (2010) Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures. Pediatrics 126(1): E1-E8. doi: 10. 1542/peds. 2010-0665.
9. Kulldorff M, Davis RL, Kolczak M, Lewis E, Lieu T, Platt R (2011) A maximized sequential probability ratio test for drug and vaccine safety surveillance. Seq Anal 30: 58-78. doi: 10. 1080/07474946. 2011. 539924.
10. Li L (2009) A conditional sequential sampling procedure for drug safety surveillance. Stat Med 28(25): 3124-3138.
11. Lieu TA, Kulldorff M, Davis RL, Lewis EM, Weintraub E, Yih K, Yin R, Brown JS, Platt R (2007) Real-time vaccine safety surveillance for the early detection of adverse events. Med Care 45(10): S89-S95.
12. McCaffrey DF, Ridgeway G, Morral AR (2004) Propensity score estimation with boosted regression for evaluating causal effects in observational studies. Psychol Methods 9(4): 403-425.
13. O'Neill RT, Szarfman A (2001) Some US food and drug administration perspectives on data mining for pediatric safety assessment. Curr Ther Res, Clin Exp 62(9): 650-663.
14. Platt R, Andrade SE, Davis RL, Destefano F, Finkelstein JA, Goodman MJ, Gurwitz JH, Go AS, Martinson BC, Raebel MA, Roblin D, Ross-Degnan D, Soumerai SB, Smith DH, Ulcickas-Yood M, Chan KA (2002) Pharmacovigilance in the HMO research network. In: Mann RD, Andrews EB (eds) Pharmacovigilance. Wiley, New York, pp 391-398.
15. Platt R, Wilson M, Chan KA, Benner JS, Marchibroda J, McClellan M (2009) The new sentinel network-improving the evidence of medical-product safety. N Engl J Med 361(7): 645-647.
16. Ridgeway G, McCaffrey DF (2007) Comment: demystifying double robustness: a comparison of alternative strategies for estimating a population mean from incomplete data. Stat Sci 22(4): 540-580.
17. Ridgeway G, McCaffrey DF, Morral AR (2009) Twang R package manual.
18. Robins JM, Hernan MA, Brumback B (2000) Marginal structural models and causal inference in epidemiology. Epidemiology 11(5): 550-560.
19. Rosenbaum P (2002) Observational studies. Springer, New York.
20. Rosenbaum PR, Rubin DB (1983) The central role of the propensity score in observational studies for causal effects. Biometrika 70(1): 41-55.
21. Rosenbaum PR, Rubin DB (1984) Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Assoc 79(387): 516-524.
22. Statistics USNCfH (2003) Age-adjusted percent distributions of body mass index (BMI) among persons 18 years old and over.
23. Szarfman A, Machado SG, O'Neill RT (2002) Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the USFDA's spontaneous reports database. Drug Safety 25(6): 381-392.
24. US Food Drug Administration (2008) The sentinel initiative: national strategy for monitoring medical product safety. Available at http://www. fda. gov/Safety/FDAsSentinelInitiative/ucm089474. htm.
25. Wald A (1945) Sequential tests of statistical hypotheses. Ann Math Stat 16: 117-186.
26. Wald A (1947) Sequential analysis. Wiley, New York.
27. Yih WK, Nordin JD, Kulldorff M, Lewis E, Lieu TA, Shi P, Weintraub ES (2009) An assessment of the safety of adolescent and adult tetanus-diphtheria-acellular pertussis (Tdap) vaccine, using active surveillance for adverse events in the Vaccine Safety Datalink. Vaccine 27(32): 4257-4262. doi: 10. 1016/j. vaccine. 2009. 05. 036.